Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran
,
Abstract
Background and Objectives: Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the world. It is usually a self-limited disease but may leads to the deaths of about 20% of pregnant women in developing countries. This study was conducted to determine the prevalence of HEV infection among HIV individuals.
Materials and Methods: This is a cross-sectional survey of HIV positive individuals in voluntary counselling and testing center of Shiraz in 2013 . Using the systematic random sampling method, 158 patients enrolled for the research. They were asked about their age, gender, area of residence, marital status, number of children, education level, occupation, history of imprisonment, mode of HIV transmission, and viral hepatitis co-infection .Three ml venous blood sample was drawn from each subject and transferred to the laboratory of voluntary counselling and testing center.
Results: The overall seroprevalence of hepatitis E was 26 (16.4%), where it increased significantly with age ranging from zero in subjects less than 30 years of age to 47.4% in those aged 50 years or older.
Conclusion: Co-infection of HIV positive individuals with HEV is an issue that should be of concern to health care providers.
Fact sheet N°280, Updated July 2013, Hepatitis E.Available from: http://www.who.int/mediacentre/fact- sheets/fs280/en/
Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, et al. Hepatitis E virus coinfection in pa- tients with HIV infection. HIV Med 2012; 13(1):83-8.
Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P, Witteck A, Darling KE, Kovari H, et al. Hepatitis E Virus seroprevalence and chronic infections in pa- tients with HIV, Switzerland. Emerg Infect Dis 2011;17:1074-1078.
Caron M, Bouscaillou J, Kazanji M. Acute risk for hep- atitis E virus infection among HIV-1-positive pregnant women in central Africa.Virol J 2012 31; 9:254.
Alavian SM, Fallafian F, Lankarani KB. Epidemiology of Hepatitis E in Iran and Pakistan. Hepat Mon 2009;9: 60-65.
Keyvani H, Shahrabadi MS, Najafifard S, Hajibeigi B, Fallahian F, Alavian M. Seroprevalence of anti-HEV and HEV RNA among volunteer blood donors and pa- tients with Hepatitis B and C in Iran. Bangladesh Liver Journal 2009;1:34-37.
Taremi M, Gachkar L, MahmoudArabi S, Kheradpe- zhouh M, Khoshbaten M. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J 2007;13:98-102.
Assarehzadegan MA, Shakerinejad G, Amini A, Re- zaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis 2008; 12:387-390.
Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Ba- bamahmodi F, SaffarH.Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Is- lamic Republic of Iran. East Mediterr Health J 2009;15:136-142.
Raoofi R, Nazer MR, Pournia Y. Seroepidemiology of hepatitis E virus in Western Iran. Braz J Infect Dis 2012; 16:302-303.
Taremi M, Mohammad Alizadeh AH, Ardalan A, An- sari S, Zali MR. Seroprevalence of hepatitis E in Na- havand, Islamic Republic of Iran: a population-based study. East Mediterr Health J 2008; 14:157-162.
Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis 2009; 13:67-71.
Ahmadi Ghezeldasht S1, Miri R, Hedayatimoghad- am M, Shamsian A, Bidkhori H, Fathimoghadam F, et al. Population movement and virus spreading: HEV spreading in a pilgrimage city, Mashhad in Northeast Iran; an Example. Hepat Mon 2013; 13:e10255.
Ehteram H, Ramezani A, Eslamifar A, Sofian M, Ban- ifazl M, Ghassemi S, et al.Seroprevalence of Hepati- tis E Virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol 2013; 5:172-176.
Rostamzadeh Khameneh Z, Sepehrvand N, Khalkha- liHR. Seroprevalence of hepatitis e among preg- nant women in Uremia, Iran. Hepat Mon 2013;13(11):e10931.
Sellier P, Mazeron MC, Tesse S, Badsi E, Evans J, Magnier JD, et al. Hepatitis E virus infection in HIV-infected patients with elevated serum transami-nases levels. Virol J 2011; 8:171.
Ramezani A, Velayati AA, Khorami-Sarvestani S, Eslamifar A, Mohraz M, Banifazl M, et al. Hepatitis E virus infection in patients infected with human im- mune deficiency virus in an endemic area in Iran. Int J STD AIDS 2013; 24:769-774.
Curry JA, Adams N, Crum-Cianflone NF. Acute Hepa- titis E Virus (HEV) Infection in an HIV-Infected Per- son in the U.S. Ann Intern Med 2009; 150: 226–227.
Mateos-Lindemann ML1, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 2014;86:71-74.
Sharipova IN, BerezhnayaAV ,Puzyrev VF, Burkov AN , Ulanova TI.Hepatitis E virus seroprevalence in- patients with HIV in Nizhny Novgorod, Russia. BMC Infect Dis 2014; 14(Suppl 2):P100.
Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, van Lunzen J, et al. Hepatit is Evirusinfections in HIV-infected patients in Ghana and Cameroon. J Clin Virol 2013; 58:18-23.
Pineda JA1, Cifuentes C, Parra M, Merchante N, Pérez-Navarro E, Rivero-Juárez A, et al. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. AIDS 2014 ;28:1931-1937.
Sherman KE1, Terrault N, Barin B, Rouster SD, Sha-ta MT. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. J Viral Hepat 2014;21(8):e74-7.
Crum-Cianflone NF, Curry J, Drobeniuc J, Weintrob A, Landrum M, Ganesan A, et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012; 18:502-506.
Mamun-Al-Mahtab, Rahman S, Khan M, KarimF.
HEV infection as an aetiologic factor for acute hepati- tis: experience from a tertiary hospital in Bangladesh. J Health Popul Nutr 2009; 27:14-19.
Kuniholm MH, Labrique AB, Nelson KE. Should HIV-infected patients with unexplained chronicliv- erenzymeelevations be tested for hepatitis E virus? Clin Infect Dis 2010 ; 50:1545-1546.
Colson P, Dhiver C, Gérolami R. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.Clin Microbi- ol Infect 2008 Dec; 14(12):1176-80.
Dalton HR, SaundersM, Woolson KL.Hepatitis E virus in developed countries: one of the most successful zoo- notic viral diseases in human history? J Virus Eradica- tion 2015; 1: 23–29.
Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S.Persistent carriage of hepatit is Evirus in patients with HIVinfection. N Engl J Med 2009; 361:1025-1027.
| Files | ||
| Issue | Vol 7 No 2 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| Hepatitis E HIV Seroprevalence | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
